Bullseye Biosciences
PrivateLast Round
Seed
Apr 24, 2025
Total Funding Raised
$3M
Momentum Score
25 /100
Company Overview
Bullseye Biosciences is a biotechnology company that operates a therapeutics discovery platform using robotics, directed evolution, and sequencing to develop medicines for oncology, immunology, and cardiometabolic diseases.
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bullseye Biosciences Comps
Public and private peers based on sector, stage, and business model.
Bullseye Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 24, 2025 |
Bullseye Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Harvard Innovation Labs | Seed |
| ZAKA VC | Seed |
| Ono Venture Investment, Inc. | Accelerator |
| Mission BioCapital | Seed, Accelerator |
| National Science Foundation | Seed |
| Illumina Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
Grew 100% QoQ from 3 to 6 employees.
- May 4, 2025
Monthly visitors increased 407% MoM.
Bullseye Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bullseye Biosciences's valuation, stock price, and market status.
